About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gfm1em2Rmrt
endonuclease-mediated mutation 2, Ramon Marti
MGI:7858915
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Gfm1em2Rmrt/Gfm1em2Rmrt C57BL/6NTac-Gfm1em2Rmrt MGI:8369245
ht2
Gfm1em1Rmrt/Gfm1em2Rmrt involves: C57BL/6J * C57BL/6NTac MGI:8369247


Genotype
MGI:8369245
hm1
Allelic
Composition
Gfm1em2Rmrt/Gfm1em2Rmrt
Genetic
Background
C57BL/6NTac-Gfm1em2Rmrt
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gfm1em2Rmrt mutation (1 available); any Gfm1 mutation (34 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
N
• mice exhibit normal exercise capacity and endurance in a treadmill test both at 4-6 weeks and at 30 weeks of age
• in organello translation assays show decreased levels of the 13 mtDNA-encoded polypeptides in liver mitochondria from 6- to 8-week-old mice, indicating a reduced mitochondrial protein synthesis rate
• levels of two mitoribosome proteins (MRPL13 and MRPS9) are significantly increased in liver, likely as a response to the mitochondrial translation defect
• however, no reductions in mitochondrial translation are detected in brain or kidney mitochondria, consistent with the normal respiratory chain enzyme activities observed in these organs
• some male mice show a moderate increase in plasma alanine aminotransferase (ALT) levels from 24 to 40 weeks of age, with no increase in plasma ALT detected in female mice
• however, H&E staining of liver sections shows signs of nonalcoholic steatohepatitis comparable to those in wild-type males at 50 weeks of age
• mitochondria-enriched extracts from brain, liver, heart, and kidney show a ~85% reduction in GFM1/EFG1 protein levels; similar reductions are noted in protein extracts from total homogenates of liver, brain, and skeletal muscle tissue, with no change of steady-state mRNA levels detected in any tissue
• however, total mRNA and mitochondrial protein levels of other mitochondrial translation elongation and termination factors are not altered in any tissue
• 6- to 8-week-old mice show a ~40% reduction in respiratory chain complex IV enzyme activity (normalized to citrate synthase activity) in the liver
• however, enzyme activity of other OXPHOS complexes (complex I, complex II, complex III, and complex II plus III) and citrate synthase activity are normal in liver
• moreover, no changes in respiratory chain enzyme activities are detected in brain, kidney, skeletal muscle or heart
• 6- to 8-week-old mice show a ~40% reduction in respiratory chain complex IV enzyme activity (normalized to citrate synthase activity) in the liver

cellular
• analysis of OXPHOS subunits levels by BN-PAGE and immunodetection using complex-specific antibodies shows a significant reduction in the relative amount of complex IV in liver mitochondria, with no change in the relative amount of other complexes
• in organello translation assays show decreased levels of the 13 mtDNA-encoded polypeptides in liver mitochondria from 6- to 8-week-old mice, indicating a reduced mitochondrial protein synthesis rate
• levels of two mitoribosome proteins (MRPL13 and MRPS9) are significantly increased in liver, likely as a response to the mitochondrial translation defect
• however, no reductions in mitochondrial translation are detected in brain or kidney mitochondria, consistent with the normal respiratory chain enzyme activities observed in these organs

liver/biliary system
• 6- to 8-week-old mice show a ~40% reduction in respiratory chain complex IV enzyme activity (normalized to citrate synthase activity) in the liver

reproductive system
• mice stop to reproduce

mortality/aging
N
• mice are born in expected Mendelian ratios and show no significant differences in long-term survival relative to wild-type and heterozygous controls

growth/size/body
N
• both sexes show normal body weight up to 50 weeks of age; relative organ weights expressed as % of total body weight are normal at 6-8 weeks of age

behavior/neurological
N
• mice exhibit normal motor coordination performance in a hanging wire test both at 4-6 weeks and at 30 weeks of age

muscle
N
• mice exhibit normal muscle strength in a weight-lift test both at 4-6 weeks and at 30 weeks of age




Genotype
MGI:8369247
ht2
Allelic
Composition
Gfm1em1Rmrt/Gfm1em2Rmrt
Genetic
Background
involves: C57BL/6J * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gfm1em1Rmrt mutation (1 available); any Gfm1 mutation (34 available)
Gfm1em2Rmrt mutation (1 available); any Gfm1 mutation (34 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• mice show a moderate reduction of mitochondrial respiratory complex I enzyme activity in liver and brain homogenates, not observed in Gfm1em2Rmrt homozygotes
• in organello translation assays show a further reduction of mitochondrial translation in liver and brain mitochondria from 8-week-old mice relative to Gfm1em2Rmrt homozygotes (which show impaired mitochondrial translation in liver, but not in brain)
• mitochondrial translation rates are below 50% of those in wild-type controls in both tissues
• mice show a more severe (~98%) depletion of GFM1/EFG1 protein levels in liver and brain mitochondria than Gfm1em2Rmrt homozygotes, with steady-state Gfm1 mRNA levels only slightly decreased in liver but normal in brain relative to wild-type levels
• moreover, a strong reduction (~97.5%) of GFM1/EFG1 protein levels is detected in heart
• however, protein levels of other mitochondrial translation elongation factors are normal in liver and brain
• mice show a slight increase in the activity of citrate synthase (a TCA cycle enzyme) in brain, but NOT in liver and heart, suggesting increased mitochondrial proliferation in this organ
• mice show a marked reduction of respiratory chain complex IV enzyme activity in liver (~38.4% of wild-type) and brain (~58.1% of wild-type) homogenates
• despite a strong reduction of cardiac GFM1/EFG1 levels, only a moderate reduction of complex IV enzyme activity is detected in heart (~62.8% of wild-type)

cellular
• mice show a moderate reduction of mitochondrial respiratory complex I enzyme activity in liver and brain homogenates, not observed in Gfm1em2Rmrt homozygotes
• mice show a slight increase in the activity of citrate synthase (a TCA cycle enzyme) in brain, but NOT in liver and heart, suggesting increased mitochondrial proliferation in this organ
• in organello translation assays show a further reduction of mitochondrial translation in liver and brain mitochondria from 8-week-old mice relative to Gfm1em2Rmrt homozygotes (which show impaired mitochondrial translation in liver, but not in brain)
• mitochondrial translation rates are below 50% of those in wild-type controls in both tissues
• pulse-chase labeling of mtDNA-encoded proteins shows that the half-life of newly synthetized MT-CO1, the core catalytic subunit of Complex IV, in liver mitochondria is shorter than in wild-type controls (1.39 h versus 2.16 h), indicating instability
• however, the stability of newly synthetized Complex I subunits MT-ND1 and MT-ND2 and Complex III MT-CYTB is not affected
• analysis of OXPHOS subunits levels by BN-PAGE and immunodetection using complex-specific antibodies shows a significant reduction in the relative amount of assembled complex I and complex IV in liver and brain mitochondria

growth/size/body
• starting at P7, female, but not male, mice show a significant reduction in body weight during the preweaning phase
• however, female body weight is normalized by 2 months of age

nervous system
• mice show a slight increase in the activity of citrate synthase (a TCA cycle enzyme) in brain, but NOT in liver and heart, suggesting increased mitochondrial proliferation in this organ

mortality/aging
N
• mice are viable and exhibit a normal lifespan

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
combined oxidative phosphorylation deficiency 1 DOID:0111474 OMIM:609060
J:361430





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
06/16/2026
MGI 6.24
The Jackson Laboratory